GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $764,000 | +6.4% | 17,542 | +7.8% | 0.04% | +23.3% |
| Q4 2021 | $718,000 | +30.1% | 16,278 | +8.3% | 0.03% | +15.4% |
| Q3 2021 | $552,000 | -3.0% | 15,034 | +6.2% | 0.03% | -7.1% |
| Q2 2021 | $569,000 | +8.2% | 14,160 | -3.6% | 0.03% | -6.7% |
| Q1 2021 | $526,000 | +14.6% | 14,688 | +17.7% | 0.03% | -9.1% |
| Q4 2020 | $459,000 | -11.0% | 12,484 | -9.0% | 0.03% | -28.3% |
| Q3 2020 | $516,000 | -10.7% | 13,717 | -3.2% | 0.05% | -20.7% |
| Q2 2020 | $578,000 | -2.4% | 14,173 | -9.2% | 0.06% | -27.5% |
| Q1 2020 | $592,000 | +8.8% | 15,617 | +35.0% | 0.08% | +17.6% |
| Q4 2019 | $544,000 | +48.2% | 11,568 | +34.5% | 0.07% | +17.2% |
| Q3 2019 | $367,000 | +58.9% | 8,598 | +48.8% | 0.06% | +48.7% |
| Q2 2019 | $231,000 | +2.2% | 5,778 | +7.0% | 0.04% | +14.7% |
| Q1 2019 | $226,000 | – | 5,401 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chubb Ltd | 400,000 | $15,404,000 | 6.76% |
| KAHN BROTHERS GROUP INC | 833,315 | $32,090,960,000 | 5.42% |
| Sio Capital Management, LLC | 180,811 | $6,963,000 | 4.06% |
| Sio Capital Management, LLC | 170,000 | $6,547,000 | 3.82% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,124,462 | $43,304,000 | 3.12% |
| Keystone Financial Planning, Inc. | 120,705 | $4,648,000 | 3.04% |
| PVG Asset Management | 186,553 | $7,184,156,000 | 3.02% |
| P.R. Herzig & Co. Inc. | 37,950 | $1,461,000 | 2.98% |
| EQUITY INVESTMENT CORP | 2,329,469 | $89,708,000 | 2.89% |
| Sterneck Capital Management, LLC | 114,816 | $4,422,000 | 2.84% |